Literature DB >> 19046474

Obsessive-compulsive disorder: subclassification based on co-morbidity.

G Nestadt1, C Z Di, M A Riddle, M A Grados, B D Greenberg, A J Fyer, J T McCracken, S L Rauch, D L Murphy, S A Rasmussen, B Cullen, A Pinto, J A Knowles, J Piacentini, D L Pauls, O J Bienvenu, Y Wang, K Y Liang, J F Samuels, K Bandeen Roche.   

Abstract

BACKGROUND: Obsessive-compulsive disorder (OCD) is probably an etiologically heterogeneous condition. Many patients manifest other psychiatric syndromes. This study investigated the relationship between OCD and co-morbid conditions to identify subtypes.
METHOD: Seven hundred and six individuals with OCD were assessed in the OCD Collaborative Genetics Study (OCGS). Multi-level latent class analysis was conducted based on the presence of eight co-morbid psychiatric conditions [generalized anxiety disorder (GAD), major depression, panic disorder (PD), separation anxiety disorder (SAD), tics, mania, somatization disorders (Som) and grooming disorders (GrD)]. The relationship of the derived classes to specific clinical characteristics was investigated.
RESULTS: Two and three classes of OCD syndromes emerge from the analyses. The two-class solution describes lesser and greater co-morbidity classes and the more descriptive three-class solution is characterized by: (1) an OCD simplex class, in which major depressive disorder (MDD) is the most frequent additional disorder; (2) an OCD co-morbid tic-related class, in which tics are prominent and affective syndromes are considerably rarer; and (3) an OCD co-morbid affective-related class in which PD and affective syndromes are highly represented. The OCD co-morbid tic-related class is predominantly male and characterized by high conscientiousness. The OCD co-morbid affective-related class is predominantly female, has a young age at onset, obsessive-compulsive personality disorder (OCPD) features, high scores on the 'taboo' factor of OCD symptoms, and low conscientiousness.
CONCLUSIONS: OCD can be classified into three classes based on co-morbidity. Membership within a class is differentially associated with other clinical characteristics. These classes, if replicated, should have important implications for research and clinical endeavors.

Entities:  

Mesh:

Year:  2008        PMID: 19046474      PMCID: PMC3039126          DOI: 10.1017/S0033291708004753

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  33 in total

1.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

2.  Latent structure of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition personality disorder criteria.

Authors:  Gerald Nestadt; Fang-Chi Hsu; Jack Samuels; O Joseph Bienvenu; Irving Reti; Paul T Costa; William W Eaton
Journal:  Compr Psychiatry       Date:  2006 Jan-Feb       Impact factor: 3.735

3.  Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes.

Authors:  Jules Angst; Alex Gamma; Jérôme Endrass; Elie Hantouche; Renée Goodwin; Vladeta Ajdacic; Dominique Eich; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-02       Impact factor: 5.270

4.  Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates.

Authors:  Christine Lochner; Sian M J Hemmings; Craig J Kinnear; Dana J H Niehaus; Daniel G Nel; Valerie A Corfield; Johanna C Moolman-Smook; Soraya Seedat; Dan J Stein
Journal:  Compr Psychiatry       Date:  2005 Jan-Feb       Impact factor: 3.735

5.  A family study of obsessive-compulsive disorder with pediatric probands.

Authors:  Gregory L Hanna; Joseph A Himle; George C Curtis; Brenda W Gillespie
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-04-05       Impact factor: 3.568

6.  Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity.

Authors:  Gregor Hasler; V Holland LaSalle-Ricci; Jonne G Ronquillo; Sarah A Crawley; Lauren W Cochran; Diane Kazuba; Benjamin D Greenberg; Dennis L Murphy
Journal:  Psychiatry Res       Date:  2005-06-15       Impact factor: 3.222

7.  Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder.

Authors:  Alice S Carter; Rachel A Pollock; Michael K Suvak; David L Pauls
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

8.  A family study of obsessive-compulsive disorder.

Authors:  D L Pauls; J P Alsobrook; W Goodman; S Rasmussen; J F Leckman
Journal:  Am J Psychiatry       Date:  1995-01       Impact factor: 18.112

9.  The identification of OCD-related subgroups based on comorbidity.

Authors:  Gerald Nestadt; Anjene Addington; Jack Samuels; Kung-Yee Liang; O Joseph Bienvenu; Mark Riddle; Marco Grados; Rudolf Hoehn-Saric; Bernadette Cullen
Journal:  Biol Psychiatry       Date:  2003-05-15       Impact factor: 13.382

10.  Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development.

Authors:  S Mannuzza; A J Fyer; D F Klein; J Endicott
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

View more
  27 in total

1.  Basal ganglia MR relaxometry in obsessive-compulsive disorder: T2 depends upon age of symptom onset.

Authors:  Stephen Correia; Emily Hubbard; Jason Hassenstab; Agustin Yip; Josef Vymazal; Vit Herynek; Jay Giedd; Dennis L Murphy; Benjamin D Greenberg
Journal:  Brain Imaging Behav       Date:  2009-12-12       Impact factor: 3.978

2.  Association between DRD4 genotype and Autistic Symptoms in DSM-IV ADHD.

Authors:  Angela M Reiersen; Alexandre A Todorov
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-02

Review 3.  The genetics of obsessive-compulsive disorder and Tourette's syndrome: what are the common factors?

Authors:  Marco A Grados
Journal:  Curr Psychiatry Rep       Date:  2009-04       Impact factor: 5.285

4.  Distinguishing Fear Versus Distress Symptomatology in Pediatric OCD.

Authors:  Michelle Rozenman; Tara Peris; R Lindsey Bergman; Susanna Chang; Joseph O'Neill; James T McCracken; John Piacentini
Journal:  Child Psychiatry Hum Dev       Date:  2017-02

Review 5.  Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.

Authors:  James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

6.  Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and OCD connection.

Authors:  Kiara R Timpano; Liza M Rubenstein; Dennis L Murphy
Journal:  Depress Anxiety       Date:  2011-11-22       Impact factor: 6.505

7.  Alternative factor models and heritability of the Short Leyton Obsessional Inventory-Children's Version.

Authors:  Janette Moore; Gillian W Smith; Mark Shevlin; Francis A O'Neill
Journal:  J Abnorm Child Psychol       Date:  2010-10

8.  Impulse-control disorders in children and adolescents with obsessive-compulsive disorder.

Authors:  Jon E Grant; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen
Journal:  Psychiatry Res       Date:  2009-12-09       Impact factor: 3.222

Review 9.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

10.  Latent class analysis of the Child Behavior Checklist Obsessive-Compulsive Scale.

Authors:  Robert R Althoff; David C Rettew; Dorret I Boomsma; James J Hudziak
Journal:  Compr Psychiatry       Date:  2009-03-10       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.